Search for: "RISING PHARMACEUTICALS, INC." Results 281 - 300 of 462
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jan 2018, 8:53 am by Schachtman
In the Harkonen case, a pharmaceutical executive was indicted and tried for wire fraud and misbranding. [read post]
26 May 2015, 7:42 am
  Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
1 Mar 2013, 2:30 pm by Bexis
McNeil-PPC, Inc., 2009 WL 1178651, at *3-4 (Pa. [read post]
30 Nov 2017, 4:26 am by Dennis Crouch
Prometheus Labs., Inc., 132 S. [read post]
2 Aug 2008, 12:54 am
, (Daily Dose of IP), 20 August – Bill Patry Copyright Blog speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry Copyright Blog speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry Copyright Blog speaking on copyright – Sydney: (Patry Copyright Blog), (LawFont.com), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat),… [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
22 Dec 2009, 8:57 pm
Cir. 2008) ("An alleged co-inventor's testimony, standing alone, cannot rise to the level of clear and convincing evidence; he must supply evidence to corroborate his testimony. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
2 Feb 2012, 4:21 am by Max Kennerly, Esq.
Komen Breast Cancer Foundation, Inc., cut all grant funding for Planned Parenthood Federation of America, Inc. [read post]
24 Jul 2013, 5:23 am by Schachtman
Salim Shah and his companies Sarfez Pharmaceuticals, Inc. and Sarfez USA, Inc. [read post]
14 Oct 2014, 8:40 am by Joy Waltemath
Thus, the court in an unpublished opinion denied without prejudice the pharmaceutical giant’s motion to dismiss and/or strike the claims (Smith v Merck & Co, Inc, October 8, 2014, Pisano, J). [read post]